JW Pharmaceutical Corp Cash Flow Quality Index
JW Pharmaceutical Corp cash flow quality index. JW Pharmaceutical Corp (001067) has a Cash Flow Quality Index of 1.53x as of September 2025. Operating cash flow of ₩46.92 Billion exceeds net income of ₩30.59 Billion, indicating high earnings quality where cash backs reported profits. See 001067 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of JW Pharmaceutical Corp (2015–2024)
Cash flow quality index of JW Pharmaceutical Corp from 2015 to 2024. Historical Cash Flow Quality Index for JW Pharmaceutical Corp across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can JW Pharmaceutical Corp service its debt to assess how comfortably operating cash covers total debt obligations.
JW Pharmaceutical Corp Cash Flow Quality Index by Year (2015–2024)
JW Pharmaceutical Corp cash flow quality index by year from 2015 to 2024. Year-by-year earnings quality comparison for JW Pharmaceutical Corp. For the full cash flow conversion analysis, see 001067 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | — |